Complying with quality requirements is a must for a scientifically & ethically valid clinical trial. Globalization, outsourcing and the increasing complexity of clinical trials has resulted in a novel compliance scenario regarding international quality standards for clinical trials.
To make it easier for you to meet regulatory expectations and quality standards for every clinical trial, Fleming has decided to organize the Clinical Quality & Compliance Masterclass.
Experts from Pfizer, Roche, Sanofi, Boehringer Ingelheim, AstraZeneca, Bayer and others will gather on 16 - 17 June 2016 in Vienna, Austria to discuss how to manage clinical quality for greater compliance, effectiveness & audit readiness.
During the two interactive days, attendees will have the opportunity to gain practical tips from a GCP inspector during an on-stage interview, get deeper insight into key drivers of clinical quality under the recent GCP guideline amendments, explore new approaches to auditing investigator sites with a risk-based monitoring model, ensure the sponsor accountabilities in the quality oversight in an outsourced model, and much more.
Participants will have the opportunity to work on practical tasks and share their results on winning tactics & strategies for achieving the highest quality, cost efficiency and operational excellence during three built-in workshops.
The full event program may be downloaded here.